> For the complete documentation index, see [llms.txt](https://www.brexatlas.org/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.brexatlas.org/bre-001/bre-041.md).
# BRE 041
## Ferroelectric Nanoparticles and Targeted Amplification of Alternating Electric Fields
**Clinical Focus:** Multi-Tissue Oncology / Cancer Bioelectronics\
**Common Focus:** Using Nanoparticles to Make Electric-Field Cancer Treatment More Precise
## Source
Cho, J., Ahn, Y., Park, M., Jang, J., Park, J., Park, S. J., Park, H. J., & Seo, D. (2025).
*Targeted amplification of alternating electric fields using ferroelectric nanoparticles.*
*npj Biomedical Innovations, 2, 45.*
***
## BRS Score
**BRS:** 9.1 / 10\
**STEMD:** S9 / T9 / E9 / M10 / D9\
**External Evidence Level:** High experimental nanobioelectric engineering evidence
### Score Interpretation
BRE-041 receives a high BRS because it provides experimental evidence that ferroelectric nanoparticles can locally amplify electric fields, enhance microtubule disruption, increase growth inhibition, enhance cell death, and improve TTFields efficiency without increasing global exposure.
***
## Entry Summary
BRE-041 asks a major precision oncology question:
Can nanoparticles make electric-field cancer treatment more targeted and more effective?
This study tested ferroelectric nanoparticles, specifically tetragonal barium titanate, with alternating electric fields.
In simple language:
Instead of increasing the strength of the electric field everywhere, nanoparticles may help concentrate the field near the cancer-cell target.
That matters because future bioelectric oncology may need to become more precise, not just stronger.
***
## What BREXAtlas Found
BREXAtlas identifies this primary mechanism chain:
```
TTFields
↓
Ferroelectric amplification
↓
Localized electric-field enhancement
↓
Microtubule disruption
↓
Reduced proliferation
```
A secondary targeting chain is:
```
Targeted nanoparticle delivery
↓
Localized field concentration
↓
Enhanced therapeutic specificity
↓
Reduced off-target exposure
```
This makes BRE-041 one of the strongest entries for precision bioelectronic oncology.
***
## Questions This BRE Helps Answer
What are ferroelectric nanoparticles?
Ferroelectric nanoparticles are tiny materials that can strongly interact with electric fields.
What BREXAtlas found:\
BRE-041 used ferroelectric nanoparticles to amplify local electric fields and enhance TTFields-like tumor suppression.
What material was used?
What BREXAtlas found:\
The extraction identifies tetragonal barium titanate, or tBTO, as the ferroelectric nanoparticle platform.
Why does local field amplification matter?
Increasing the whole-body or global field may increase exposure concerns.
Local amplification is different.
What BREXAtlas found:\
BRE-041 supports the idea that nanoparticles may improve TTFields efficiency without increasing global exposure.
Is this the same as standard TTFields?
What BREXAtlas found:\
No.
This is a TTFields-like / alternating electric-field amplification strategy using ferroelectric nanoparticles. It should be treated as a precision engineering extension of TTFields, not simply standard TTFields alone.
***
## Study Classification
| Category | Classification |
| ------------------------------------------------- | ------------------------------------------------------------------------------------------- |
| Study Type | Experimental nanobioelectric oncology study |
| Tissue Category | Cancer bioelectronics; TTFields amplification systems; multi-tissue oncology |
| Models | U2OS cancer systems; TTFields-compatible cell systems; ferroelectric nanoparticle platforms |
| Exposure Type | Alternating electric fields / TTFields-like exposure |
| Amplification Platform | Ferroelectric nanoparticles |
| Material | Tetragonal barium titanate / tBTO |
| Direct TTFields-Like Evidence | Yes |
| Direct Nanotechnology Evidence | Yes |
| Suitable for Nanobioelectric Index | Yes |
| Suitable for Precision Bioelectronics Index | Yes |
| Suitable for Frequency / Field Optimization Index | Yes |
***
## Mechanisms
* **MEC-001: Mitotic Disruption**\
BRE-041 strengthens the mitotic disruption pathway by enhancing microtubule disruption under electric-field exposure.
* **MEC-002: Frequency Specificity**\
Local amplification may interact with frequency-specific field response, though more mapping is needed.
* **MEC-020: Dielectrophoretic Force Effects**\
Ferroelectric nanoparticles may enhance local electric-field interactions relevant to dielectrophoretic effects.
* **MEC-034: Ferroelectric Nanoparticle Amplification**\
Ferroelectric nanoparticles may locally amplify electric fields and increase TTFields-like tumor suppression.
* **MEC-096: Precision Bioelectronic Targeting**\
Nanoparticles may allow electric-field effects to become more localized and target-specific.
* **MEC-097: Local Field Concentration**\
BRE-041 supports localized electric-field enhancement as a therapeutic design strategy.
***
## Discoveries
* **DISC-006: Mitotic Structural Collapse Network**\
BRE-041 strengthens the mitotic structural-collapse pathway by enhancing microtubule disruption.
* **DISC-014: Ferroelectric Amplification of TTFields**\
BRE-041 strongly supports the discovery that ferroelectric nanoparticles may amplify TTFields-like effects.
* **DISC-021: Clinical Systems-Level TTFields Integration**\
BRE-041 adds future engineering relevance to clinical TTFields systems by suggesting that field delivery may be improved through precision amplification.
* **DISC-026: Precision Nanobioelectric Oncology**\
BREXAtlas identifies this as a major discovery:
Nanoparticle-assisted electric-field amplification may become a precision bioelectronic oncology strategy.
***
## Connections to Other BRE Entries
### Connected to BRE-022
BRE-022 showed barium titanate nanoparticles sensitized treatment-resistant breast cancer cells to TTFields.
BRE-041 strengthens that same nanobioelectric pathway with targeted amplification of alternating electric fields.
### Connected to BRE-021
BRE-021 emphasized frequency optimization, field distribution, and clinical translation.
BRE-041 adds a precision engineering answer: local field amplification may improve field delivery without increasing global exposure.
### Connected to BRE-016
BRE-016 focused on localized electric-field concentration during cytokinesis.
BRE-041 extends localized-field logic into nanoparticle-mediated targeting.
### Connected to BRE-036
BRE-036 described clinical TTFields translation in glioblastoma.
BRE-041 points toward a future version of TTFields systems that may become more targeted through nanoparticle-assisted amplification.
### Connected to BRE-040
BRE-040 expanded TTFields into liposarcoma using ROS-mediated apoptosis and doxorubicin sensitization.
BRE-041 is different because it does not focus on chemotherapy sensitization; it focuses on improving field delivery itself.
***
## Research Gaps Identified
* **RG-203: Nanoparticle Delivery Gap**\
More research is needed to determine how ferroelectric nanoparticles can be safely delivered to tumors.
* **RG-204: Local Field Dosimetry Gap**\
Future work must measure how much local field amplification occurs at the tumor-cell level.
* **RG-205: Off-Target Exposure Gap**\
More testing is needed to determine whether local amplification reduces or increases risk to nearby normal tissue.
* **RG-206: Frequency-Nanoparticle Interaction Gap**\
More work is needed to understand how nanoparticle amplification changes frequency-specific response.
* **RG-207: Clinical Translation Gap**\
This remains an experimental nanobioelectric engineering platform and requires extensive preclinical and clinical validation.
***
## Scientific Caution
BRE-041 provides experimental nanobioelectric engineering evidence, but clinical translation requires validation of nanoparticle delivery, biodistribution, safety, local dosimetry, tumor specificity, and long-term outcomes.
***
## Why This Entry Matters
For researchers, BRE-041 is important because it changes the question from “Can electric fields affect cancer?” to “Can electric fields be targeted and amplified at the tumor level?”
For patients and families, the simple idea is this:
Nanoparticles may one day help electric-field treatments focus more strongly on cancer cells while avoiding unnecessary exposure elsewhere.
This is not a standard treatment. It is an engineering pathway for future precision bioelectric oncology.
***
## Entry Conclusion
BRE-041 is a major precision nanobioelectric oncology entry.
BRE-022 introduced barium titanate nanoparticles as TTFields sensitizers in breast cancer.
BRE-041 expands that idea into targeted amplification of alternating electric fields using ferroelectric nanoparticles.
The central question emerging from this entry is:
Can ferroelectric nanoparticles make electric-field cancer therapy more targeted, more efficient, and more precise?
For BREXAtlas, BRE-041 is essential because it links TTFields, nanotechnology, field amplification, tumor targeting, and future precision bioelectronic oncology.
---
# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.
## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.
Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:
```
GET https://www.brexatlas.org/bre-001/bre-041.md?ask=&goal=
```
`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.
The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.
Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.